Abstract
The first known reference to rhabdomyolysis is said to be in the Bible in the Book of Numbers, [1] in which an illness is described that occurred in Israelites after eating hemlock-fed quail. Rhabdomyolysis is a potentially life-threatening syndrome that can develop from a variety of causes. The term “Rhabdomyolysis” literally translates to “dissolution of striped [skeletal] muscle.” It is the final common pathway of a number of different processes, all of which end in skeletal muscle injury. An elevated plasma creatinine kinase (CK) level is the most sensitive laboratory finding pertaining to muscle injury; whereas hyperkalemia, acute kidney injury, and compartment syndrome represent the major life-threatening complications [2]. The clinical and biochemical syndrome of rhabdomyolysis occurs when skeletal muscle cell disruption causes release of muscle cell contents (CK, lactate dehydrogenase, aldolase, myoglobin, purines, potassium, and phosphates) into the interstitial space and plasma. Although direct mechanical trauma, compression, excessive muscle activity, and ischemia are frequent causes, direct xenobiotic-induced rhabdomyolysis results from toxic insult to the cell membrane, affecting its ability to maintain ion gradients. Although rhabdomyolysis does not indicate irreversible necrosis of muscle, life-threatening illness and multi-organ insufficiency may result [3, 4].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Billis AG. Acute renal failure after a meal of quail. Lancet. 1971;2:702.
Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009;67:272–83.
Brady HR, Brenner BM, Lieberthal W. Acute renal insufficiency. In: Brenner BM, editor. The kidney. 5th ed. Philadelphia: WB Saunders; 1996.
Firth JD, Winerls CG. Acute renal insufficiency. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. 3rd ed. Oxford: Oxford University Press; 1996.
Jo YI, Song JO, Park JH, et al. Risk factors for rhabdomyolysis following doxylamine overdose. Hum Exp Toxicol. 2007;26:617–21.
Saviuc P, Danel V. New syndromes in mushroom poisoning. Toxicol Rev. 2006;25:199–209.
Luck RP, Verbin S. Rhabdomyolysis review of clinical presentation, etiology, diagnosis and management. Pediatr Emerg Care. 2008;24:262–8.
Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal insufficiency. Kidney Int. 1996;49:314–26.
Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol. 1993;5:725–31.
Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis – an overview for clinicians. Crit Care. 2005;9:158–69.
Hamemes M, Gillum DM, Brennan S. Acute renal insufficiency. In: Hall JB, Schmidt GA, Wood LDH, editors. Principles of critical care. 2nd ed. New York: McGraw-Hill; 1998. p. 1117–32.
Knochel JP. Rhabdomyolysis and myoglobinuria. Semin Nephrol. 1981;1:75–86.
Braun SR, Weiss FR, Kellar AL, et al. Evaluation of the renal toxicity of heme pigments and their derivatives: a role in the genesis of acute tubular necrosis. J Exp Med. 1970;131:443–60.
Corcoran AC, Page IH. Renal damage from ferroheme pigments in myoglobin, hemoglobin, hematin. Tex Rep Biol Med. 1945;3:528–44.
David WS. Myoglobinuria. Neurol Clin. 2000;18:215–43.
[ToxED] Mannix R, Daubert GP. “Rhabdomyolysis.” ToxED: the clinician’s toxicology resource. Elsevier/Gold Standard, 25 Sept 2015. Web. 1 Dec 2015.
Muthukumar T, Jha V, Sud A, et al. Acute kidney injury due to non-traumatic rhabdomyolysis following binge drinking. Ren Fail. 1999;12:545–9.
Ward MM. Factors predictive of acute kidney injury in rhabdomyolysis. Arch Intern Med. 1988;148:1553–7.
Perkoff GT, Dioso MM, Bleish V, Klinkerfuss G. A spectrum of myopathy associated with alcoholism: I. Clinical and laboratory features. Ann Intern Med. 1967;67:481–2.
Hojs R, Ekart R, Sinkovic A, Hojs-Fabja T. Rhabdomyolysis and acute kidney injury in intensive care unit. Ren Fail. 1999;21:675–84.
Deighhan CH, Wong KM, McLaughlin KJ, Harden P. Rhabdomyolysis and acute kidney injuryresulting from alcohol and drug abuse. QJM. 2000;93:29–33.
Womboldt D, Jackson A, Punn R, et al. Case report: rhabdomyolysis induced by mibetradil in a patient treated with cyclosporine and simvastatin. J Clin Pharmacol. 1999;39:310–2.
Moßhammer D, Schaeffeler E, Schwab M, Mörike K. Mechanisms and assessment of statin-related muscular adverse effects. Br J Clin Pharmacol. 2014;78:454–66.
Carr DF, O’Meara H, Jorgensen AL, et al. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink. Clin Pharmacol Ther. 2013;94:695–701.
Khan FY, Ibrahim W. Rosuvastatin induced rhabdomyolysis in a low risk patient: a case report and review of the literature. Curr Clin Pharmacol. 2009;4:1–3.
Puccetti L, Ciani F, Auteri A. Genetic involvement in statins induced myopathy preliminary data from an observational case–control study. Atherosclerosis. 2010;211:28–9.
Ruaño G, et al. Mechanisms of statin-induced myalgia assessed by physiogenomic associations. Atherosclerosis. 2011;218:451–6.
Omar MA, Wilson JP. FDA adverse event reports on statin-associated rhabdomyolysis. Ann Pharmacother. 2002;36:288–95.
Mendoza FS, Atiba JO, Krensky AM, et al. Rhabdomyolysis complicating doxylamine overdose. Clin Pediatr (Phila). 1987;26:595–7.
Frankel D, Dolgin J, Murrray BM. Non-traumatic rhabdomyolysis complicating antihistamine overdose. J Toxicol Clin Toxicol. 1993;31:493–6.
Soto LF, Miller CH, Ognibere AJ. Severe rhabdomyolysis after doxylamine overdose. Postgrad Med. 1993;93:227–32.
Kim HJ, Oh SH, Youn CS, et al. The associative factors of delayed-onset rhabdomyolysis in patients with doxylamine overdose. Am J Emerg Med. 2011;29:903–7.
Koppel C, Ibe K, Oberdisse U. Rhabdomyolysis in doxylamine overdose. Lancet. 1987;21:442–3.
Choi OK, Yoo JY, Kim MS, et al. Acute drug intoxication in ED of urban area. J Korean Soc Emerg Med. 1995;2:324–9.
Lee SY, Kang YS, Han SY, et al. Rhabdomyolysis complicating doxylamine overdose. Korean J Nephrol. 2001;20:120–6.
Park SH, Choi HS, Ko YG, et al. The relation between rhabdomyolysis and microscopic hematuria in doxylamine ingested patients. Korean J Nephrol. 2005;24:618–25.
Nieminen P, Mustonen AM, Kirsi M. Increased plasma creatine kinase activities triggered by edible wild mushrooms. Food Chem Toxicol. 2005;43:133–8.
De Pinho PG, Ribeiro B, Goncalves RF, et al. Correlation between the pattern volatiles and the overall aroma of wild edible mushrooms. J Agric Food Chem. 2008;56:1704–12.
Carlton BE, Tufts E, Girard DE. Water hemlock poisoning complicated by rhabdomyolysis and renal failure. Clin Toxicol. 1979;14:87–92.
Costanza DJ, Hoversten VW. Accidental ingestion of water hemlock report of two patients with acute and chronic effects. Calif Med. 1973;119:78–82.
Ball MJ, Flather ML, Forfar JC. Hemlock water dropwort poisoning. Postgrad Med. 1987;63:363–5.
Pogue VA, Nurse HM. Cocaine-associated acute myoglobinuric renal failure. Am J Med. 1989;68:183–6.
Rubin RB, Neugarten J. Cocaine- induced rhabdomyolysis masquerading as myocardial ischemia. Am J Med. 1989;86:551–3.
Welch RD, Todd K, Krause GS, et al. Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med. 1991;20:154–7.
Brody SL, Wrenn KD, Wilber MM, et al. Predicting the severity of cocaine-associated rhabdomyolysis. Ann Emerg Med. 1990;19:1137–43.
Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417–25.
Amrein S, Amrein K, Amegah-Sakotnik A, Reist U, Ensner R. Propofol infusion syndrome – a critical incident report highlighting the danger of reexposure. J Neurosurg Anesthesiol. 2011;23:265–6.
Motsch J, Roggenbach J. Propofol infusion syndrome. Anaesthesist. 2004;53:1009–20.
Krajčová A, Waldauf P, Anděl M, Duška F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398.
Hohenegger M. Drug induced rhabdomyolysis. Curr Opin Pharmacol. 2012;12:335–9.
Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet. 1999;354:866–7.
Schenkman KA, Yan S. Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy. Crit Care Med. 2000;28:172–7.
Wolf A, Weir P, Segar P, Stone J, Shield J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606–7.
Mirrakhimov AE, Voore P, Halytskyy O, et al. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract. 2015;2015:1–10.
Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine. 1982;61:141–52.
Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care. 2014;224:1–8.
Woodrow G, Brownjohn AM, Turney JH. The clinical and biochemical features of acute kidney injury due to rhabdomyolysis. Ren Fail. 1995;17:467–74.
Haapanen E, Partanen J, Pellinen TJ. Acute kidney injury following nontraumatic rhabdomyolysis. Scand J Urol Nephrol. 1998;22:305–8.
Koppel C. Clinical features, pathogenesis and management of drug-induced rhabdomyolysis. Med Toxicol Adverse Drug Exp. 1989;4:108–26.
Stadhoudes AM. Cellular calcium homeostasis, mitochondria and muscle cell disease. In: Busch HFM, Jennekens FGI, Scholte HR, editors. Mitochondria and muscular diseases. Beetsterzwaag: Mefar b.v; 1981. p. 77–88.
Zager RA. Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest. 1989;60:619–29.
Anderson WAD, Morrison DB, Williams Jr EF. Pathologic changes following injection of ferrihemate (hematin) in dogs. Arch Pathol. 1942;33:589–602.
Poel PJE, Gabreels FHM. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg. 1993;95:175–92.
Horowitz BZ, Panacek EA, Jouriles NJ. Severe rhabdomyolysis with renal insufficiency after intranasal cocaine use. J Emerg Med. 1997;15:833–7.
Visweswaran P, Guntupalli J. Rhabdomyolsys. Environ Emerg. 1999;15:415–28.
Sandhu JS, Sood A, Midha V, et al. Nontraumatic rhabdomyolysis with acute renal insufficiency. Ren Fail. 2000;22:81–6.
Cervellin G, Comelli I, Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. 2010;48:749–56.
Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144:1058–65.
Knottenbelt JD. Traumatic rhabdomyolysis from severe beating – experience of volume diuresis in 200 patients. J Trauma. 1994;37:214–9.
Homsi E, Barreiro M, Orlando J, Higa E. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail. 1997;19:283–8.
Lane R, Philps M. Rhabdomyolysis has many causes, including statins, and may be fatal. BMJ. 2003;327:115–6.
Curry SA, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med. 1989;18:1068–84.
Better OS, Abbassi ZA. Early fluid resuscitation in patients with rhabdomyolysis. Nat Rev Nephrol. 2011;7:416–22.
Ferguson E, Blachley Y, Carter N, Knochel JD. Derangements of muscle composition, ion transport and oxygen consumption in clinically alcoholic dogs. Am J Physiol. 1984;246:700–9.
Cho YS, Lim H, Kim SH. Comparison of lactated Ringer’s solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication. Emerg Med J. 2007;24:276–80.
Haapanen E, Partanen J, Pellinen TJ. Acute renal failure following nontraumatic rhabdomyolysis. Scand J Urol Nephrol. 1988;22:305–8.
Brochard L, Abroug F, Brenner M, et al. ATS/ERS/ESICM/SCCM/SRLF Ad Hoc Committee on Acute Renal Failure. An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med. 2010;181:1128–55.
Eneas JF, Schoenfeld PY, Humphreys MH. The effect of infusion of mannitol-sodium bicarbonate on the clinical course of myoglobinuria. Arch Intern Med. 1979;139:801–5.
Ron D, Taitelman U, Michaelson M, et al. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med. 1984;144:277–80.
Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361:62–72.
Heyne N, Guthoff M, Krieger J, et al. High cut-off renal replacement therapy for removal of myoglobin in severe rhabdomyolysis and acute kidney injury: a case series. Nephron Clin Pract. 2012;121:159–64.
Tang W, Chen Z, Wu W, et al. Renal protective effects of early continuous venovenous hemofiltration in rhabdomyolysis: improved renal mitochondrial dysfunction and inhibited apoptosis. Artif Organs. 2013;37:390–400.
Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J. Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med. 1999;25:1169–72.
Akmal M, Bishop J, Telfer N, et al. Hypocalcemia and hypercalcemia in patients with and without acute renal insufficiency. J Clin Endocrinol Metab. 1986;63:137–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Grading System for Levels of Evidence Supporting Recommendations in Critical Care Toxicology, 2nd Edition
-
I
Evidence obtained from at least one properly randomized controlled trial.
-
II-1
Evidence obtained from well-designed controlled trials without randomization.
-
II-2
Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group.
-
II-3
Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments (such as the results of the introduction of penicillin treatment in the 1940s) could also be regarded as this type of evidence.
-
III
Opinions of respected authorities, based on clinical experience, descriptive studies and case reports, or reports of expert committees.
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Daubert, G.P. (2017). Toxicant-Induced Rhabdomyolysis. In: Brent, J., et al. Critical Care Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-319-17900-1_106
Download citation
DOI: https://doi.org/10.1007/978-3-319-17900-1_106
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17899-8
Online ISBN: 978-3-319-17900-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences